Verve Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	60	59	145	207	215	-
Market Cap Growth	-59.70%	-59.70%	-29.83%	-3.53%	-	-
Enterprise Value	58	56	141	199	200	-
Last Close Price	0.23	0.23	0.57	0.82	0.86	-
PE Ratio	-	-	-	-	10.45	-
PS Ratio	-6.64	-6.50	-20.36	195.95	5.51	-
PB Ratio	2.04	2.00	3.93	4.99	4.91	-
P/TBV Ratio	2.04	2.00	3.93	4.99	4.91	-
EV/Sales Ratio	-	-	-	188.05	5.14	-
EV/EBIT Ratio	-	-	-	-	7.48	-
Asset Turnover	-	-	-	0.02	1.21	-
Quick Ratio	3.37	3.37	4.96	1.87	0.65	-
Current Ratio	3.76	3.76	4.97	1.88	0.66	0.53
Return on Equity (ROE)	-23.76%	-23.76%	-17.00%	-5.72%	94.28%	-
Return on Assets (ROA)	-14.58%	-14.58%	-12.49%	-3.33%	52.10%	-
Return on Capital (ROIC)	-18.86%	-18.86%	-17.10%	-4.79%	76.83%	-
Return on Capital Employed (ROCE)	-	-	-	-	53.10%	-
Earnings Yield	-13.16%	-13.45%	-4.59%	-1.18%	9.57%	-
Buyback Yield / Dilution	-1.52%	-1.52%	-0.12%	-23.99%	-1938.47%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.